Kayne Anderson Rudnick Investment Management’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14
Closed -$1.74K 1099
2025
Q2
$1.74K Buy
+14
New +$1.78K ﹤0.01% 862
2021
Q1
Sell
-7
Closed -$1K 698
2020
Q4
$1K Buy
+7
New +$1.27K ﹤0.01% 657

Other funds holding RGEN

Kayne Anderson Rudnick Investment Management's RGEN Position: Q3 2025 in Review

Kayne Anderson Rudnick Investment Management sold out of Repligen (RGEN) in Q3 2025, closing a stake of 14 shares — an estimated $1.74K sold.

Kayne Anderson Rudnick Investment Management first reported a position in RGEN in Q4 2020 and held it in 2 quarters. The position peaked at $1.74K in Q2 2025. 453 funds tracked by Wall St. Rank hold RGEN as of Q3 2025.

  • Kayne Anderson Rudnick Investment Management reported no remaining Repligen position as of Q3 2025 after selling out during the quarter.
  • Kayne Anderson Rudnick Investment Management sold 14 Repligen shares in Q3 2025, an estimated $1.74K.
  • Kayne Anderson Rudnick Investment Management first reported a position in Repligen in Q4 2020 and held it in 2 quarters.
  • Kayne Anderson Rudnick Investment Management's Repligen position peaked at $1.74K in Q2 2025.
  • 453 funds tracked by Wall St. Rank held Repligen as of Q3 2025.

Based on Kayne Anderson Rudnick Investment Management's 13F filing for Q3 2025, filed 13 Nov 2025.